3//SEC Filing
Conjoint Inc. 3
Accession 0001104659-25-026302
CIK 0001818844other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 8:19 PM ET
Size
7.0 KB
Accession
0001104659-25-026302
Insider Transaction Report
Form 3
Conjoint Inc.
Director10% OwnerOther
Holdings
Series A-1 Preferred Stock
→ Common Stock (2,842,638 underlying)
Footnotes (2)
- [F1]Following stockholder approval of the conversion of the Issuer's Series A-1 Non-Voting Convertible Preferred Stock, par value $0.0001 per share ("Series A-1 Preferred Stock"), into shares of the Issuer's Common Stock, par value $0.0001 per share ("Common Stock"), each share of the Series A-1 Preferred Stock will be convertible into 10,000 shares of Common Stock, subject to waiver by the Reporting Person of a beneficial ownership limitation of 19.99% of the outstanding Common Stock. The shares of Series A-1 Preferred Stock have no expiration date.
- [F2]On March 12, 2025, the Reporting Person entered into a Debt Exchange and Cancellation Agreement with the Issuer pursuant to which $19,500,000 in principal amount of all loans made to the Issuer under a Loan Agreement, dated October 7, 2024 (the "Loan Agreement"), between the Reporting Person and the Issuer, along with accrued interest through March 12, 2025 (as of such date, an aggregate of $19,926,891), was deemed repaid and all of the Issuer's obligations under the Loan Agreement with respect to the principal amount and accrued interest was satisfied in full and cancelled in exchange for 284.2638 shares of Series A-1 Preferred Stock, based on a price per underlying share of Common Stock of $7.01. This transaction involved an acquisition of shares in connection with a debt previously contracted.
Documents
Issuer
Dogwood Therapeutics, Inc.
CIK 0001818844
Entity typeother
IncorporatedHong Kong
Related Parties
1- filerCIK 0002061651
Filing Metadata
- Form type
- 3
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 8:19 PM ET
- Size
- 7.0 KB